2024年4月18日，兴欣新材公布分红方案，每10股转增4股，派息(税前)12元。除权除息日2024年4月24 日，股权登记日2024年4月23日。 上市首日，该股最高价报65.66元，为截至目前的股价最高峰。目前该股处于破发状态。 兴欣新材本次公开发行募集资金总额为90,200.00万元，扣除不含税发行费用后募集资金净额为80,958.80 万元。公司募集资金净额比原计划多25,958.8万元。兴欣新材2023年12月18日披露的招股说明书显示， 公司拟募集资金55,000.00万元，用于"年产14,000吨环保类溶剂产品及5,250吨聚氨酯发泡剂项 目""8,800t/a哌嗪系列产品、74,600t/a重金属螯合剂、1,000t/a双吗啉基乙基醚项目""研发大楼建设项 目""补充流动资金"。 公司本次发行的保荐机构为国盛证券有限责任公司，保荐代表人为韩逸驰、孙蓓。兴欣新材本次发行费 用总额(不含增值税)为9,241.20万元，其中保荐及承销费用6,314.00万元。 中国经济网北京5月28日讯兴欣新材（001358）(001358.SZ)今日股价下跌，截至收盘报23.39元，跌幅 1.85%。 2023年 ...

证券代码：603086 证券简称：先达股份 公告编号：2025-026 | 产品 | 主要产品 | 2023 年平均售价 | 2024 年平均售价 | 变动比率（%） | | --- | --- | --- | --- | --- | | 类别 | | （万元/吨） | （万元/吨） | | | 除草剂 | 烯草酮系列 | 9.02 | 7.63 | -15.41 | | | 咪草烟系列 | 20.03 | 15.19 | -24.16 | | | 灭草烟系列 | 24.43 | 19.98 | -18.22 | | | 异噁草松系列 | 8.70 | 7.46 | -14.25 | | 杀菌剂 | 烯酰吗啉系列 | 6.00 | 6.00 | 0.00 | 三、主要原材料的价格变动情况 | 主要原材料 | 2023 年平均进价 | 2024 | 年平均进价 | 变动比率（%） | | --- | --- | --- | --- | --- | | | （万元/吨） | | （万元/吨） | | | 氯代特戊酰氯 | 2.08 | 1.74 | -16.35 | | --- | --- | --- | --- ...

一、主要产品的产量、销量及收入实现情况 证券代码：603086 证券简称：先达股份 公告编号：2025-027 山东先达农化股份有限公司 2025 年第一季度主要经营数据公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 根据上海证券交易所《上市公司行业信息披露指引第十八号—化工》等相关 规定，山东先达农化股份有限公司（以下简称"公司"）现将 2025 年第一季度 主要经营数据披露如下（均不含税）： | 产品 | 主要产品 | 2025 年 | 1-3 | 月产 | 2025 | 年 1-3 | 月销 | 2025 年 | 1-3 | 月销 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 类别 | | | 量（吨） | | | 量（吨） | | 售金额（万元） | | | | 除草剂 | 烯草酮系列 | | 2,977.16 | | | 2,325.88 | | 17,844.45 | | | | | 咪草烟系列 | | 6 ...

Core Viewpoint - The company, Hualitai, reported a decline in revenue and net profit for the year 2024, indicating ongoing challenges in the chemical industry due to macroeconomic factors and increased competition [1][2]. Financial Performance - In 2024, Hualitai achieved revenue of 1.641 billion yuan, a year-on-year decrease of 8.42% - Net profit for the same period was 87.74 million yuan, down 44.56% year-on-year - The company's net profit has been on a downward trend for three consecutive years, with figures of 220 million yuan, 158 million yuan, and 87.74 million yuan from 2022 to 2024, representing declines of 47.12%, 27.98%, and 44.56% respectively [1][2]. Quarterly Performance - For Q1 2025, Hualitai reported revenue of 471 million yuan, a year-on-year increase of 19.25% - However, net profit for the quarter was 17.03 million yuan, reflecting a significant decline of 48.9% year-on-year [1]. Industry Context - The decline in performance is attributed to several factors, including a slowdown in macroeconomic growth affecting downstream demand for chemical products, intensified market competition due to new capacity expansions, and increased operational costs from R&D and other expenses [1][2]. Product Segmentation - Hualitai's main products include nitric acid, sulfuric acid, hydrogen peroxide, and melamine, with a focus on both basic and fine chemicals - Revenue from the basic chemical segment was 1.244 billion yuan, down 9.22%, with a gross margin of 17.84%, a decrease of 2.79 percentage points - Revenue from the fine chemical segment was 397 million yuan, down 5.81%, with a gross margin of 0.27%, a decrease of 0.58 percentage points [2]. Capacity Utilization - The company maintains high capacity utilization rates for its main products, with nitric acid at 118%, hydrogen peroxide at 96%, and sulfuric acid at 88% [2]. Expansion and Upgrades - Hualitai is actively pursuing capacity expansion and technological upgrades, with projects such as the ammonia synthesis energy-saving upgrade and a new 150,000-ton nitric acid project completed on schedule - The company is also working on a 60,000-ton electronic-grade hydrogen peroxide project, which is ready for production [3]. Investment Project Performance - Many of Hualitai's initial public offering (IPO) fundraising projects have not met expected benefits - The 10,000-ton N-methyl morpholine project has incurred cumulative losses of 38.94 million yuan since its launch in 2022 - The 150,000-ton hydrogen peroxide project has achieved cumulative benefits of 46.75 million yuan, but did not meet the forecasted benefits due to changes in market conditions - The cogeneration project has also fallen short of expectations, with cumulative benefits of 34.87 million yuan due to insufficient steam demand from downstream users [3]. Dividend Distribution - Hualitai plans to distribute a cash dividend of 1 yuan per 10 shares to all shareholders in 2024, amounting to approximately 33.19 million yuan, which represents 37.82% of its net profit [4].